Psoriasiform Dermatitis in a COVID-19 Patient

Area of Science:

• Dermatology
• Infectious Diseases
• Immunology

Background:

• Psoriasis is a chronic inflammatory skin condition affecting 2% of the global population.
• The COVID-19 pandemic exacerbated psoriatic symptoms due to limited dermatological access and increased stress.
• Psoriasiform lesions are skin manifestations that require careful differential diagnosis.

Observation:

• A 52-year-old male presented with a diffuse rash preceding a positive COVID-19 test.
• The patient's rash appeared on multiple body areas.
• The case report includes clinical images and a review of similar dermatological presentations.

Findings:

• The report explores potential causes for the patient's psoriasiform rash in the context of COVID-19.
• A treatment plan for the patient's condition is discussed.
• Literature review highlights the importance of differentiating systemic diseases presenting with similar cutaneous lesions.

Implications:

• Accurate diagnosis of systemic manifestations linked to cutaneous lesions is crucial for dermatologists.
• Further research is needed to understand the association between COVID-19 infection and psoriasiform lesions.
• Improved understanding can enhance prognostic and therapeutic strategies for affected patients.